Introductionof shares to trading on the main market operated by the Warsaw StockExchange following the assimilation of shares in the National Depositoryfor Securities. Setting the date of the first listing of the Company'sseries K shares after their assimilation with shares traded on the mainmarket.

CurrentReport No.: 31/2025

Date:October 13, 2025

LegalBasis: Article 56(1)(2) of the Act on Public Offering - Current andPeriodic Information

TheManagement Board of Medicalgorithmics S.A. with its registered office inWarsaw (the "Issuer", the "Company") herebyannounces that on 13 October 2025 it was informed that the ManagementBoard of the Warsaw Stock Exchange ("WSE") adoptedResolution No. 1297/2025, which is attached to this report, on theadmission and introduction to stock exchange trading on the WSE MainMarket of series K ordinary bearer shares of Medicalgorithmics S.A. (the"Resolution").

Inaccordance with the Resolution, 1,433,197 (one million four hundredthirty-three thousand one hundred and ninety-seven) series K ordinarybearer shares of the Company, with a nominal value of 0.10 (ten groszy)each, designated by the National Depository for Securities ("KDPW")with the code "PLMDCLG00064" ("Shares") wereadmitted to trading on the main market. Pursuant to the Resolution, theWSE Management Board decided to introduce the above-described CompanyShares to stock exchange trading on the main market as of 15 October2025, subject to the KDPW assimilating these Shares with the Company'slisted shares marked with the code "PLMDCLG00015" on 15 October 2025.

Atthe same time, the Management Board of the Company announces that on 13October 2025 it became aware of the issuance on 10 October 2025 of astatement by the National Depository for Securities on the assimilationof ordinary bearer shares of the Company (the "Statement").In accordance with the Statement, KDPW decided to assimilate 1,433,197ordinary bearer shares marked with the code PLMDCLG00064 ("Shares")with the Company's shares traded on the stock exchange, marked with thecode PLMDCLG00015. The date of assimilation in the deposit system of theNational Depository is 15 October 2025.

Therefore,the condition precedent for the introduction of the Shares to tradingreferred to in the WSE Resolution will be met on 15 October 2025 and theShares will be introduced to stock exchange trading on the main marketas of that date. The KDPW's Statement is attached to this report.

TheCompany reminds that the Shares were issued in accordance with theResolution No. 4 of the Company's Extraordinary General Meeting ofOctober 28, 2022 Increase of the Company's share capital through issueof series I, J, K and L shares; waiver of existing shareholders'subscription rights; private subscription offer for a designated entity;and change of Article 5 (1) and (2) of the Articles of Association. Theshares were registered with the National Securities Depository on March7, 2023, as the Company announced in current report number 8/2023 onMarch 8, 2023.

TheCompany reminds that in the current report No. 55/2022 it informed onOctober 1, 2022, that 4,976,384 Shares were acquired by Biofund CapitalManagement LLC with its registered office in Miami (USA). These sharesare to be introduced to trading under the applicable exceptions to theobligation to prepare an issue prospectus, and the planned date ofintroducing all these shares to trading has been set at the end of 2026.

Attachmentsto the report:

1.WSE Resolution No. 1297/2025,